Hepion Pharma director Danina Fisher acquires $10,000 in common shares

PUBT · 2d ago
Hepion Pharma director Danina Fisher acquires $10,000 in common shares
  • Hepion director Danina Fisher reported a purchase of 200,000 common shares at $0.05 per share.
  • Fisher’s direct ownership rose to 200,000 shares following the transaction.
  • She also bought 200,000 warrants with a $0.06 exercise price, exercisable immediately through 09/29/2031.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hepion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-045526), on October 02, 2026, and is solely responsible for the information contained therein.